Lewy Body Dementia Treatment Market: Emerging Advances in Neurological Care
The Lewy body dementia treatment market focuses on therapies and medications designed to manage the symptoms of Lewy body dementia (LBD), a progressive neurodegenerative disease characterized by cognitive decline, motor dysfunction and psychiatric symptoms. Current options primarily include cholinesterase inhibitors, dopaminergic agents and antipsychotic drugs, alongside non-pharmacological...
0 Kommentare 0 Anteile 219 Ansichten 0 Vorschau